TKTL1 Overexpression in Non-Small Cell Lung Cancer
Author Information
Author(s): Holger Schultz, Daniel Kähler, Detlev Branscheid, Ekkehard Vollmer, Peter Zabel, Torsten Goldmann
Primary Institution: Research Center Borstel
Hypothesis
Does TKTL1 expression correlate with clinical parameters in non-small cell lung cancer?
Conclusion
A significant portion of non-small cell lung cancer specimens overexpress TKTL1, but no correlation with clinical parameters was found.
Supporting Evidence
- 40.9% of lung tumors expressed TKTL1 weakly, 38.6% moderately, and 17.1% strongly.
- All breast cancer specimens stained positive for TKTL1.
- 3.4% of lung tumors were TKTL1-negative.
Takeaway
This study looked at a protein called TKTL1 in lung cancer and found that many tumors have high levels of it, but it doesn't seem to relate to other health factors.
Methodology
Immunohistochemical staining of 88 non-small cell lung cancer tissues and 24 breast cancer specimens to assess TKTL1 expression.
Limitations
No significant correlation was found between TKTL1 expression and clinical parameters.
Participant Demographics
88 non-small cell lung cancer tissues (39 adenocarcinomas, 49 squamous cell carcinomas) and 24 breast cancer specimens.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website